Science & Technology
Science and Technology
Science and Technology
Tue, September 29, 2009
Mon, September 28, 2009
Accelrys: Accelrys Announces Annual European User Group Conference
SAN DIEGO, CA--(Marketwire - September 28, 2009) - Accelrys, Inc. (
Plenary sessions by customers include:
-- "Agile Development Using Information Analytics," Nick Brown, AstraZeneca -- "Anchors a Way to Improved Clustering?," Brad Sherborne, Schering Plough -- "Fast Multi-objective Design of Combinatorial Libraries Using Pareto Ranking," Rob Smith, Pfizer -- "Finding Needles in a Haystack," Karen Abraham, Unilever -- "Integrating Imaging Workflows in Pipeline Pilot: Portal for Image Analysis and Results Reporting," Keith Neil, Sanofi-Aventis
Customers will also present in the Chemistry Track, Biology Track, IT Track, Chemicals Materials and Manufacturing Track, Modeling and Simulation Track, and SharePoint, Reporting and Web Applications Track.
"We're honored to have so many distinguished guests sharing their successes and exchanging ideas at our European User Group Meeting," said Max Carnecchia, president and CEO of Accelrys. "This conference creates a strong forum for our partners and customers to discuss industry and market trends so that we can better offer solutions that make processes involving scientific information more efficient, enabling companies to better leverage the vast amounts of scientific data they possess."
For more information about the 2009 Accelrys European User Group Conference, visit [ http://accelrys.com/events/ugms/eugm-2009/ ]
About Accelrys, Inc.
Headquartered in San Diego, California, Accelrys [ develops scientific business intelligence ] software and solutions for the life sciences, energy, chemicals, aerospace, and consumer products [ industries ]. [ Customers ] include many Fortune 500 companies and other commercial entities, as well as academic and government entities. Accelrys has a vast portfolio of computer-aided design modeling and simulation offerings which assist customers in conducting scientific experiments 'in silico' in order to reduce the duration and cost of discovering and developing new drugs and materials. Its [ scientific business intelligence platform ] underlies the company's computer-aided design modeling and simulation offerings. The Accelrys platform can be used with both Accelrys and competitive products, as well as with customers' proprietary predictive science products. Its flexibility, ease-of-use and advanced chemical, text and image analysis and reporting capabilities enable customers to mine, aggregate, analyze and report scientific data from disparate sources, thereby better utilizing scientific data within their organizations. For more information about Accelrys, visit [ http://accelrys.com/ ]
